Viral factors
• Extensive viral clade and sequence diversity
• Early establishment of latent viral reservoirs
• Viral evasion of humoral and cellular immune responses
• Immune correlates of protection unclear
• Antibody responses typically type-specific
Research limitations
• No method yet exists to elicit broadly reactive NAbs
• Limited interest from the pharmaceutical industry
•Funding Challenges
|
|
